Latest Earnings Results: Q2 '26
Estimated EPS
-$0.08
Reported EPS
-$0.19
Surprise
-126.64%
Estimated Rev
$628.66M
Reported Rev
$613.2M
Surprise
-2.46%
Accendra Health updated its full year 2026 outlook, projecting revenue of $2.45 billion to $2.55 billion, adjusted EBITDA of $300 million to $320 million, and free cash flow as breakeven to slightly positive.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.01 | -- | -- | N/A |
Q2 '26 | -$0.08 | -$0.19 | -126.64% | MISSED |
Q1 '26 | -$0.10 | -$0.04 | 59.31% | BEAT |
Q4 '25 | $0.22 | $0.21 | -5.05% | MISSED |
Q3 '25 | $0.67 | $0.25 | -62.96% | MISSED |